Boston Scientific (NYSE:BSX) was upgraded by JMP Securities (NYSE:JMP) from market perform to outperform with a price target of $9, as the company should experience strong growth during the next several years.
Shares are higher by about three tenths of a percent.
Eaton Vance (NYSE:EV) was upgraded by Goldman Sachs (NYSE:S) from sell to neutral with a price target of $29.50 due to a better cash flow outlook.
Shares are higher by about four tenths of a percent.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.